(Reuters) - A federal judge on Wednesday overturned a U.S. jury's verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg.
(Reuters Health) - The proportion of U.S. adults who get recommended colon cancer screenings has never been as high as doctors would like, but a new study suggests that it’s much lower than expected in some pockets of the country.
PARIS (Reuters) - Higher foie gras prices and large public subsidies have allowed farmers to overcome two consecutive bird flu crises that ravaged duck flocks in southwest France, but output will take time to recover, producers said on Wednesday.
DUBLIN (Reuters) - Ireland will hold a referendum on May 25 on whether or not to liberalize its abortion law, the first opportunity in 35 years to overhaul one of the world's strictest regimes that has long divided the once deeply Catholic nation.
JOHANNESBURG (Reuters) - Tests at an RCL Foods processed-food factory found no traces of a strain of listeria that has killed almost 200 people, but they did find evidence of other strains that could also cause the disease, the South African Ministry of Health said on Wednesday.
GAZA (Reuters) - A small group of Palestinian women in Gaza are stretching their limbs with yoga to help them teach others to cope with the stresses and traumas of living in the embattled territory.
NEW YORK (Reuters) - The U.S. Food & Drug Administration is working on around a dozen actions to boost use of cheaper versions of expensive biotech medicines, the head of the agency Scott Gottlieb said on Wednesday.
TEL AVIV (Reuters) - Israel plans to collect data over five years for its digital health project and hopes 100,000 people will volunteer to include their medical records in a database it estimates could bring the country billions of dollars in annual income.
NEW YORK (Reuters) - The head of the U.S. Food & Drug Administration Scott Gottlieb said on Wednesday that he was concerned about the impact of deals like the CVS Health purchase of Aetna Inc on the ability of pharmaceutical companies to block the entry of cheaper copycat drugs.
ZURICH (Reuters) - Swiss drugmaker Roche's shares dropped on Wednesday after it told U.S.-based haemophilia advocacy groups that five patients treated with its medicine Hemlibra had died, while maintaining that the therapy was not the cause of the deaths.